Pandion Therapeutics Inc
(PAND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 12-2019 | 12-2018 | |
| Sales | 2,632 | 1,955 | 0 | 0 |
| Gross Profit | 2,632 | 1,955 | N/A | N/A |
| Operating Income | 2,632 | 1,955 | N/A | N/A |
| Pre-tax Income | 2,632 | 1,955 | 0 | 0 |
| Net Income Continuous | -11,896 | -9,237 | N/A | N/A |
| Net Income | $-11,896 | $-9,237 | $N/A | $N/A |
| EPS Basic Total Ops | -0.51 | -10.15 | N/A | N/A |
| EPS Basic Continuous Ops | -0.51 | -7.84 | N/A | N/A |
| EPS Diluted Total Ops | -0.51 | -10.15 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.51 | -7.84 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.51 | -10.15 | N/A | N/A |
| EBITDA(a) | $2,632 | $1,955 | $N/A | $N/A |